Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating Three Times Daily Levetiracetam in Epilepsy
NCT07490769Phase 3Recruiting
- Sponsor
- Waad Alkathiri
- Start
- Oct 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levetiracetam in epilepsy, sponsored by Waad Alkathiri. Started Oct 2025; status: recruiting.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT07490769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07490769.